Maiiada Nazmy
- Hepatology top 10%
- Liver physiology and pathology 5
- Hepatitis C virus research 3
- Epidemiology top 10%
- Liver Disease Diagnosis and Treatment 11
- Pharmacology top 10%
- Drug-Induced Hepatotoxicity and Protection 4
-
- Bioactive Compounds and Antitumor Agents 2
-
- Cancer therapeutics and mechanisms 5
-
- Synthesis and biological activity 3
-
- Chemotherapy-induced organ toxicity mitigation 3
- Co-authors
- John DillonPaul J. MeakinTadayuki TsujitaSudhir ChowdhryJohn D. HayesShaun WalshMichael L.J. AshfordAlbena T. Dinkova‐Kostova
- Partner nations
- EgyptSaudi ArabiaJapan
In The Last Decade
Maiiada Nazmy
32 papers receiving 570 citations
Peers
Comparison fields: 5 of 76
- Hepatology 90
- Epidemiology 262
- Endocrinology, Diabetes and Metabolism 99
- Pharmacology 47
- Toxicology 18
Countries citing papers authored by Maiiada Nazmy
This map shows the geographic impact of Maiiada Nazmy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maiiada Nazmy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maiiada Nazmy more than expected).
Fields of papers citing papers by Maiiada Nazmy
This network shows the impact of papers produced by Maiiada Nazmy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maiiada Nazmy. The network helps show where Maiiada Nazmy may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Maiiada Nazmy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2023 | 5 | |
| 3 | 2023 | 10 | |
| 4 | 2023 | 11 | |
| 5 | 2023 | 2 | |
| 6 | 2022 | 10 | |
| 7 | 2020 | 5 | |
| 8 | 2020 | 26 | |
| 9 | 2020 | 7 | |
| 10 | 2018 | 11 | |
| 11 | 2017 | 24 | |
| 12 | 2016 | 2 | |
| 13 | 2016 | 6 | |
| 14 | Serum markers versus histopathological scoring for discrimination between experimental fatty liver and non-alcoholic steatohepatitis | 2015 | 3 |
| 15 | 2015 | 10 | |
| 16 | 2015 | 7 | |
| 17 | 2015 | 9 | |
| 18 | 2012 | 18 | |
| 19 | 2011 | 17 | |
| 20 | 2009 | 220 |
About Maiiada Nazmy
Maiiada Nazmy is a scholar working on Hepatology, Toxicology and Pharmacology, having authored 33 papers that have together received 575 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (11 papers), Liver physiology and pathology (5 papers), Cancer therapeutics and mechanisms (5 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), Synthesis and biological activity (3 papers), Hepatitis C virus research (3 papers), Chemotherapy-induced organ toxicity mitigation (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). The work is most often cited by research in Hepatology (90 citations), Epidemiology (262 citations) and Endocrinology, Diabetes and Metabolism (99 citations). Maiiada Nazmy has collaborated with scholars based in Egypt, Saudi Arabia and Japan. Frequent co-authors include John Dillon, Paul J. Meakin, Tadayuki Tsujita, Sudhir Chowdhry, John D. Hayes, Shaun Walsh, Michael L.J. Ashford, Albena T. Dinkova‐Kostova, Moustafa Fathy and Nabil Mohie Abdel‐Hamid. Their work appears in journals such as Hepatology, Free Radical Biology and Medicine and Molecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.